Showing results (101-110 of 232) with videos related to

Sort By:
Pageof 24
BMC Cancer|December 9, 2009
Inverse correlation between PDGFC expression and lymphocyte infiltration in human papillary thyroid carcinomasOve Bruland, Øystein Fluge, Lars A Akslen, et al.
Journal of Cancer Policy|August 7, 2025
Long-term quality of life and quality adjusted life years after breast cancer: Impact of detection mode, tumor characteristics and treatmentNataliia Moshina, Ragnhild S Falk, Edoardo Botteri, et al.
Gynecologic Oncology|July 7, 2009
Plasma calprotectin concentrations in women with endometrial carcinomaHannah Ni Bhriain, Jone Trovik, Elisabeth Wik, et al.
Genes, Chromosomes & Cancer|May 10, 2005
A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutationAnders Molven, Magne B Grimstvedt, Solrun J Steine, et al.
Clinical Epidemiology|May 22, 2018
High mortality due to cutaneous melanoma in Norway: a study of prognostic factors in a nationwide cancer registryTrude Eid Robsahm, Per Helsing, Yngvar Nilssen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|March 15, 2015
Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivityMartin Biermann, Jostein Kråkenes, Katrin Brauckhoff, et al.
International Journal of Oncology|January 19, 2008
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomasIngeborg B Engelsen, Ingunn M Stefansson, Rameen Beroukhim, et al.
Ebiomedicine|May 5, 2023
Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent diseaseHilde E Lien, Hege F Berg, Mari K Halle, et al.
Gynecologic Oncology|October 8, 2003
Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysisFarhad Alexander-Sefre, Helga B Salvesen, Andy Ryan, et al.
Plos One|March 9, 2016
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast CancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Pageof 24